Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Newsletter subscription
Beauty
Health
Lifestyle
Medicine
Biowatch
Column
Kormedi.com TV
Notice
Languages
ENGLISH
English (US)
ASIAN
Монгол
日本語
Tiếng Việt
Bahasa Indonesia
中文 (简体, 中国大陆)
EUROPEAN
Русский
Español (España)
Français (France)
MIDDLE_EAST_AFRICA
العربية
Search results for "dosing"
Home
Daewoong Pharmaceutical Moves to Develop Once-Monthly GLP-1 Obesity Injection
Daewoong Pharmaceutical is teaming up with a biotech startup to develop an obesity treatment administered by injection just once a month.
05/12/2026, 05:17 ET
Vabysmo Prefilled Syringe Gains Reimbursement, Expanding Retina Treatment Options
Injectable therapies for chronic eye diseases are entering a new era where clinicians and patients can select formulations based on specific clinical...
04/01/2026, 21:04 ET
Alteogen to Present Subcutaneous ADC Formulation Research at International Forum in June
Alteogen announced on the 23rd that it will present research results regarding subcutaneous dosing for antibody-drug...
03/24/2026, 02:47 ET
Celltrion Secures Canadian Approval for ‘Steqeyma’ Autoinjector Formulation
Celltrion announced on March 20, 2026, that it has received additional approval from Health Canada for the autoinjector...
03/23/2026, 02:59 ET
Huwons Lab SC Formulation Change Platform, Will It Succeed in the Market?
Huwons Global's subsidiary Huwons Lab is challenging the formulation change platform business that converts intravenous...
03/17/2026, 01:44 ET
SK Chemicals Launches High-Dose 300 mg Joins for Osteoarthritis Treatment
SK Chemicals has announced the release of a new high-dose version of Joins, its flagship natural product-based...
03/13/2026, 02:22 ET
High Efficacy and Increased Convenience: The Three Obesity Drugs Awaiting FDA Approval
Since the World Health Organization recommended the use of obesity medications for adults last December, the market is...
02/06/2026, 03:39 ET
Dementia Injection Drug ‘Lecanemab’ Formulation and Dosage Diversification... Will It Compete with Oral Medications?
American Biogen and Japanese Eisai are moving quickly to change the formulation and dosage of the dementia treatment...
01/29/2026, 04:48 ET
Can We Break Through Chemotherapy Resistance? A New Target for Triple-Negative Breast Cancer Appears
Among breast cancers, ‘triple-negative breast cancer ’ is particularly challenging to treat.
01/23/2026, 02:46 ET
Oral Obesity Drug Launched in the U.S.… Where is K-Bio Pharmaceutical Now?
Denmark's Novo Nordisk's obesity drug ‘Wegovy Pill (ingredient name Semaglutide)’ has recently been launched in the U. S.
01/08/2026, 17:50 ET
Previous
2
3
4
5
Next